Treatt Q1 revenues in line with expectations, Q2 starts 'well'.

Natural extracts and ingredients business Treatt said on Thursday that Q1 revenues were in line with internal expectations and that Q2 had "started well".

Treatt
30 January 2025 10:23:23

Source: Sharecast

Treatt said it was encouraged by a "robust pipeline and order intake". It also noted cash generation continued to be a focus and remains in line with management expectations for the full year.

In its Heritage unit, Treatt said it continued to leverage its deep knowledge and product capabilities to provide solutions against a market backdrop of continued high orange oil prices, and also said it remains focussed on growing higher margin Premium volumes, stating it was "well placed" with opportunities with both new and existing customers.

In its New Markets division, Treatt's China business continued to "progress well" ahead of the opening of its Shanghai Innovation Centre later in FY25.

As of 1020 GMT, Treatt shares were down 0.017% at 429.92p.

Reporting by Iain Gilbert at Sharecast.com

N/A

ISIN: N/A

Exchange: N/A

Sell:

N/A

Buy:

N/A

Change:

Date:

Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

View our accounts

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.